Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Kura Oncology, Inc. - Common Stock (NQ:KURA)

6.730 +0.160 (+2.44%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 767,850
Open 6.590
Bid (Size) 6.690 (1)
Ask (Size) 6.860 (10)
Prev. Close 6.570
Today's Range 6.590 - 6.920
52wk Range 5.410 - 23.48
Shares Outstanding 68,438,576
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Earnings Scheduled For May 1, 2025
Via Benzinga
Uncovering Potential: Kura Oncology's Earnings Preview
Via Benzinga

Performance

YTD
-22.5%
-22.5%
1 Month
+19.2%
+19.2%
3 Month
-10.6%
-10.6%
6 Month
-36.9%
-36.9%
1 Year
-69.5%
-69.5%

More News

Read More
Excelerate Energy, MediaAlpha And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Earnings Scheduled For February 26, 2025
Via Benzinga
Here’s Why Shuttle Pharma is the Most Undervalued Biotech Stock in Our Coverage Universe
Via Stocktwits
Kura Oncology Cancer Study Hits Primary Goal, Lays Out Plans For Phase 3 Studies
Via Benzinga
These stocks are moving in today's after hours session
Via Chartmill
2 Incredible Growth Stocks to Buy Hand Over Fist
Via The Motley Fool
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Nasdaq Edges Higher; Baidu Shares Fall After Q3 Results
Via Benzinga
Crude Oil Gains 1%; Deere Posts Better-Than-Expected Earnings
Via Benzinga
Exposures Fossil Fuels
Dow Jumps Over 100 Points; Nvidia Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
Kura Oncology Slams The Door On Its Takeover Narrative, And Shares Collapse 26%
Via Investor's Business Daily
Kura Oncology Inc. (NASDAQ: KURA) is a Stock Spotlight on 3/6
Via Investor Brand Network
Kura Oncology: Q4 Earnings Insights
Via Benzinga
Earnings Scheduled For February 27, 2024
Via Benzinga
Earnings Outlook For Kura Oncology
Via Benzinga
Maximus Reports Weak Earnings, Joins Atkore, PDD Holdings And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
This Caterpillar Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday
Via Benzinga
KURA Stock Earnings: Kura Oncology Beats EPS for Q2 2024
Via InvestorPlace
7 ‘Death Cross’ Stocks That Could Be Contrarian Buys
Via InvestorPlace
Acute Myeloid Leukemia is on the Rise as Biotechs Race to Develop Groundbreaking Therapies
Via FinancialNewsMedia
Acute Myeloid Leukemia is on the Rise as Biotechs Race to Develop Groundbreaking Therapies
From FN Media Group LLC
Via GlobeNewswire
KURA Stock Earnings: Kura Oncology Misses EPS for Q1 2024
Via InvestorPlace
MAIA Biotechnology: Undervalued With Eye-Popping Cancer Data And Partnership Potential
Via Talk Markets

Frequently Asked Questions

Is Kura Oncology, Inc. - Common Stock publicly traded?
Yes, Kura Oncology, Inc. - Common Stock is publicly traded.
What exchange does Kura Oncology, Inc. - Common Stock trade on?
Kura Oncology, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Kura Oncology, Inc. - Common Stock?
The ticker symbol for Kura Oncology, Inc. - Common Stock is KURA on the Nasdaq Stock Market
What is the current price of Kura Oncology, Inc. - Common Stock?
The current price of Kura Oncology, Inc. - Common Stock is 6.730
When was Kura Oncology, Inc. - Common Stock last traded?
The last trade of Kura Oncology, Inc. - Common Stock was at 06/06/25 04:00 PM ET
What is the market capitalization of Kura Oncology, Inc. - Common Stock?
The market capitalization of Kura Oncology, Inc. - Common Stock is 460.59M
How many shares of Kura Oncology, Inc. - Common Stock are outstanding?
Kura Oncology, Inc. - Common Stock has 461M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.